Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
11.26%
operating margin TTM
25.57%
revenue TTM
190.13 Million
revenue per share TTM
14.64$
valuation ratios | |
|---|---|
| pe ratio | 0.13 |
| peg ratio | -0.00 |
| price to book ratio | 0.02 |
| price to sales ratio | 0.02 |
| enterprise value multiple | -0.10 |
| price fair value | 0.02 |
profitability ratios | |
|---|---|
| gross profit margin | 70.01% |
| operating profit margin | 25.57% |
| pretax profit margin | 19.4% |
| net profit margin | 11.26% |
| return on assets | 8.78% |
| return on equity | 17.39% |
| return on capital employed | 27.44% |
liquidity ratios | |
|---|---|
| current ratio | 1.70 |
| quick ratio | 1.27 |
| cash ratio | 0.50 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 183.75 |
| operating cycle | 268.42 |
| days of payables outstanding | 73.02 |
| cash conversion cycle | 195.40 |
| receivables turnover | 4.31 |
| payables turnover | 5.00 |
| inventory turnover | 1.99 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 0.29 |
| long term debt to capitalization | 0.19 |
| total debt to capitalization | 0.22 |
| interest coverage | 20.01 |
| cash flow to debt ratio | 0.45 |
cash flow ratios | |
|---|---|
| free cash flow per share | 2.38 |
| cash per share | 4.28 |
| operating cash flow per share | 2.38 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.45 |
| short term coverage ratios | 4.93 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) reported earnings?
Eagle Pharmaceuticals, Inc. (EGRX) published its most recent earnings results on 08-08-2023.
What is Eagle Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)'s trailing twelve months ROE is 17.39%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Eagle Pharmaceuticals, Inc. (EGRX) currently has a ROA of 8.78%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did EGRX's net profit margin stand at?
EGRX reported a profit margin of 11.26% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is EGRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.70 in the most recent quarter. The quick ratio stood at 1.27, with a Debt/Eq ratio of 0.29.